Authors: T. Pika 1; Z. Heřmanová 2; P. Flodrová 3 Authors‘ workplace: Hematoonkologická klinika, LF UP a FN Olomouc 1; Ústav imunologie, LF UP a FN Olomouc 2; Ústav klinické a molekulární patologie, LF UP a FN Olomouc 3 Published in: Klin. Biochem. Metab., 25, 2017, No. 2, p. 56-58
The aim of the communication is to remind the issue and the clinical significance of selected laboratory parameters used in the diagnosis and monitoring of patients with AA amyloidosis. Correct typing of amyloid masses, exclusion of AL type of amyloidosis, and in particular the clarification of the underlying disease are among the most important aspects in the diagnosis of disease. An essential prerequisite in the treatment of AA amyloidosis is a control of underlying process with a reduction of amyloidogenic serum amyloid A levels.
Keywords: AA amyloidosis, serum amyloid A, laboratory examination.
1. Sipe, J. D., Benson, M. D., Buxbaum, J. N. et al. Amy-loid fibril protein nomenclature: 2010 recommendations from the nomenclature committe of International Society of Amyloidosis. Amyloid, 2010, 17, p. 101-104.
2. Merlini, G., Bellotti, V. Molecular mechanisms of amyloidosis. N. Engl. J. Med., 2003, 349, p. 583-596.
3. Merlini, G., Seldin, D. C., Gertz, M. A. Amyloidosis: pathogenesis and new therapeutic options. J. Clin. Oncol., 2011, 29, p. 1924-1933.
4. de Asúa, D. R., Costa, R., Galván, J. M., Filigheddu, M. T., Trujillo, D., Cadinanos, J. Systemic AA amyloidosis: epidemiology, diagnosis, and management. Clin. Epidemiol., 2014, 6, p. 369 – 377.
5. Joss, N., McLaughlin, K., Simpson, K., Boulton-Jones, J. M. Presentation, survival and prognostic markers in AA amyloidosis. Q. J. Med., 2000, 93, p. 535 – 542.
6. Lachmann, H. J. Secondary, AA, amyloidosis. In Gertz, M. A. et al. Amyloidosis: Diagnosis and treatment. New York: Springer Humana Press, 2010, p. 179 – 189.
7. Ryšavá, R. AA amyloidóza. In Ryšavá, R. Systémové amyloidózy a jejich léčba. Praha: Maxdorf, 2013, p. 27 – 45.
8. Westermark, G. T., Fändrich, M., Westermark, P. AA amyloidosis: pathogenesis and targeted therapy. Annu Rev Pathol., 2015, 10, p. 321 – 344.
9. Kuroda, T., Wada, Y., Nakano, M. Diagnosis and treatment of AA amyloidosis with rheumatoid Arthritis: State of the art. In Sarantseva, S. Amyloidosis – Mechanisms and prospects for therapy. In Tech. ISBN: 978-953-307-253-1. 2011, p. 43 – 62.
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
